UPDATE 3-Akorn row overshadows Fresenius' generics guidance
July 31, 2018 at 09:30 AM EDT
* CEO says expect case to be resolved by early 2019 (Adds CEO comments from analyst call)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|